ResMed director plans Rule 144 sale of 970 shares

Director Peter C. Farrell has filed a Rule 144 notice covering an intended sale of 970 ResMed common shares.

Rhea-AI Filing Summary

ResMed Inc (RMD) is the issuer for a Rule 144 notice filed for planned sales by director Peter C. Farrell. The notice covers an intended sale of 970 shares of common stock, with Merrill Lynch listed as broker, following earlier Rule 144-reportable sales in the prior three months.

Key Figures

Shares intended to be sold: 970 shares Planned sale broker: Merrill Lynch Past 3-month sale volume: 8,000 shares +3 more

6 metrics

Shares intended to be sold 970 shares Common stock covered by the Rule 144 notice

Planned sale broker Merrill Lynch Broker listed for the 970 shares of common stock

Past 3-month sale volume 8,000 shares Common stock sold on August 5, 2026

Past 3-month sale proceeds $1,799,642.92 Total proceeds from 8,000 shares sold on August 5, 2026

Option grant date November 11, 2015 Stock option referenced for the securities to be sold

Issuer phone number 858-746-2400 ResMed Inc issuer contact phone

Key Terms

Rule 144, Form 144, Stock Option

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option financial

"Common | 11/11/2015 | Stock Option | Peter C Farrell"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

FAQ

What does the Form 144 filing mean for ResMed Inc (RMD)?

The filing reports that director Peter C. Farrell has given notice under Rule 144 of an intended sale of ResMed common stock. It is a disclosure of potential sales, not an execution report, and does not by itself change ResMed’s operations or financial position.

How many ResMed (RMD) shares are covered by this Rule 144 notice?

The Rule 144 notice covers an intended sale of 970 shares of ResMed common stock. These shares are to be sold through Merrill Lynch, as indicated in the broker information section of the notice.

Who is the insider selling ResMed (RMD) shares in this Form 144?

The notice identifies Peter C. Farrell, a director of ResMed Inc, as the person for whose account the securities are to be sold. The filing provides his name and role in connection with the planned Rule 144 sale.

What prior ResMed (RMD) stock sales are disclosed in the last 3 months?

The filing discloses that 8,000 shares of ResMed common stock were sold on August 5, 2026, for total proceeds of $1,799,642.92. This transaction is listed under securities sold during the past three months.

What type of ResMed (RMD) securities is Peter C. Farrell planning to sell?

The notice relates to common stock of ResMed Inc. It also references a stock option dated November 11, 2015 in the securities-to-be-sold section, indicating the shares are connected to that option grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 07:16 PM Accepted by SEC EDGAR 09/02/2026 - 07:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001186102
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ResMed INC
SEC File Number
Address of Issuer	9001 Spectrum Center Blvd SAN DIEGO CALIFORNIA 92123
Phone	858-746-2400
Name of Person for Whose Account the Securities are To Be Sold	Peter C Farrell
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 2049 Century Park East, Ste 1200 Los Angeles CA 90067	970	227608.41	144252306	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2015	Stock Option	Peter C Farrell			970	11/11/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	08/05/2026	8000	1799642.92

144: Remarks and Signature

Remarks
Date of Notice	09/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	PETER C FARRELL
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)